Comparator: MK0517 + Comparator: ondansetron
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-Operative Nausea and Vomiting
Conditions
Post-Operative Nausea and Vomiting
Trial Timeline
Jul 1, 2005 → Nov 1, 2005
NCT ID
NCT00231777About Comparator: MK0517 + Comparator: ondansetron
Comparator: MK0517 + Comparator: ondansetron is a phase 3 stage product being developed by Merck for Post-Operative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00231777. Target conditions include Post-Operative Nausea and Vomiting.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00231777 | Phase 3 | Completed |
Competing Products
18 competing products in Post-Operative Nausea and Vomiting